EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C17H18ClN3O4 |
| Net Charge | 0 |
| Average Mass | 363.801 |
| Monoisotopic Mass | 363.09858 |
| SMILES | CC(NCC1CCCO1)=C1C(=O)NC(=O)N(c2ccc(Cl)cc2)C1=O |
| InChI | InChI=1S/C17H18ClN3O4/c1-10(19-9-13-3-2-8-25-13)14-15(22)20-17(24)21(16(14)23)12-6-4-11(18)5-7-12/h4-7,13,19H,2-3,8-9H2,1H3,(H,20,22,24) |
| InChIKey | RGCKYJOSEHCNTI-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Application: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| 1-(4-chlorophenyl)-5-[1-(2-oxolanylmethylamino)ethylidene]-1,3-diazinane-2,4,6-trione (CHEBI:109059) is a barbiturates (CHEBI:22693) |
| Manual Xrefs | Databases |
|---|---|
| LSM-20457 | LINCS |